All In Biotech

Investigational drug · Phase 2

and oxaliplatin

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma.

Phase 2

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

2

2 still active

All registered trials

3,025

Any phase or sponsor naming "and oxaliplatin"

First trial start

2020

Nov 3, 2020

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "and oxaliplatin", any sponsor or status.

Conditions studied

As listed on its trial records.

  • HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma

Approved drugs for the same conditions: Stomach and esophageal cancer · Lymphoma (non-Hodgkin) · Oncology · Hematology and blood cancers · Gastroenterology and liver

Largest trials

Live from ClinicalTrials.gov: studies naming "and oxaliplatin" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 5,086 on PubMed

Also in development for HER2 Expression Gastric Cancer/Gastroesophageal Junction Adenocarcinoma

  • SHR-A1811Trastuzumab RezetecanPhase 327 trials

    Jiangsu HengRui Medicine Co., Ltd. · Advanced Colorectal Cancer, Recurrent or Metastatic Cervical Cancer, Ovarian Cancer

  • AdabelimumabSHR-A2102, SHR2554Phase 320 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumors, Prostate Cancer, Advanced Urothelial Carcinoma

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.